Parabilis Medicines, Inc.Parabilis Medicines, Inc.
PBLSFog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Market cap
No dataNo data
Revenue
No dataNo data
Net income
No dataNo data
Free cash flow
No dataNo data
The balance sheet features a large cash position and minimal liabilities, conferring substantial liquidity and unused leverage capacity. Quarterly financial performance, earnings quality, and growth-profitability metrics are unavailable due to data quality issues.
As of 2026-06-30Market
Listed stock
PBLSPriceNasdaqLoading…Loading…1Y